Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart’s Top Stock Pick. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Adma Biologics (ADMA)

Adma Biologics (ADMA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 530,164
  • Shares Outstanding, K 196,357
  • Annual Sales, $ 80,940 K
  • Annual Income, $ -71,650 K
  • 60-Month Beta 0.94
  • Price/Sales 6.50
  • Price/Cash Flow N/A
  • Price/Book 4.29
Trade ADMA with:

Options Overview Details

View History
  • Implied Volatility 85.15% ( -3.99%)
  • Historical Volatility 66.69%
  • IV Percentile 21%
  • IV Rank 14.29%
  • IV High 371.43% on 05/11/22
  • IV Low 37.41% on 10/15/21
  • Put/Call Vol Ratio 0.68
  • Today's Volume 313
  • Volume Avg (30-Day) 592
  • Put/Call OI Ratio 0.18
  • Today's Open Interest 30,880
  • Open Int (30-Day) 29,437

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate -0.08
  • Number of Estimates 2
  • High Estimate -0.07
  • Low Estimate -0.09
  • Prior Year -0.13
  • Growth Rate Est. (year over year) +38.46%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.24 +20.54%
on 09/29/22
2.92 -7.53%
on 09/08/22
-0.11 (-3.91%)
since 09/02/22
3-Month
1.97 +37.06%
on 08/09/22
2.92 -7.53%
on 09/08/22
+0.57 (+26.76%)
since 07/05/22
52-Week
1.01 +167.33%
on 10/21/21
2.92 -7.53%
on 09/08/22
+1.56 (+136.84%)
since 10/05/21

Most Recent Stories

More News
Why ADMA Biologics Stock Triumphed on Thursday

Investors were pleasantly surprised by the company's latest set of quarterly figures.

ADMA : 2.70 (+0.75%)
Adma Biologics (ADMA) Reports Q2 Loss, Tops Revenue Estimates

Adma Biologics (ADMA) delivered earnings and revenue surprises of 22.22% and 8.77%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

ADMA : 2.70 (+0.75%)
VTGN : 0.1626 (-0.12%)
ADMA Biologics Announces Second Quarter 2022 Financial Results and Provides Business Update

2Q2022 Total Revenues Were $33.9 Million, a 90% Y-o-Y Increase Grew 2Q2022 Gross Profit to $7.8 Million, Up 112% Over 1Q2022 Narrowed 2Q2022 Net Losses...

ADMA : 2.70 (+0.75%)
Cyclerion Therapeutics, Inc. (CYCN) Reports Q2 Loss, Misses Revenue Estimates

Cyclerion Therapeutics, Inc. (CYCN) delivered earnings and revenue surprises of 8.82% and 56.90%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?...

CYCN : 0.9402 (+0.77%)
ADMA : 2.70 (+0.75%)
Analysts Estimate Vascular Biogenics (VBLT) to Report a Decline in Earnings: What to Look Out for

Vascular Biogenics (VBLT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

VBLT : 0.1675 (-1.47%)
ADMA : 2.70 (+0.75%)
Adma Biologics (ADMA) May Report Negative Earnings: Know the Trend Ahead of Q2 Release

Adma Biologics (ADMA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ADMA : 2.70 (+0.75%)
NEO : 9.15 (-1.08%)
Editas Medicine (EDIT) Reports Q2 Loss, Tops Revenue Estimates

Editas (EDIT) delivered earnings and revenue surprises of 7.14% and 19.54%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

EDIT : 12.53 (-3.24%)
ADMA : 2.70 (+0.75%)
ADMA Biologics to Report Second Quarter 2022 Financial Results on August 10, 2022

Conference Call Scheduled for August 10, 2022, at 4:30 p.m. ET...

ADMA : 2.70 (+0.75%)
Seattle Genetics (SGEN) Reports Q2 Loss, Tops Revenue Estimates

Seattle Genetics (SGEN) delivered earnings and revenue surprises of 10.98% and 12.26%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

SGEN : 136.87 (-1.65%)
ADMA : 2.70 (+0.75%)
ADMA Biologics Announces Addition to the Russell 2000® Index

Ramsey, N.J. and Boca Raton, Fla., June 21, 2022 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end...

ADMA : 2.70 (+0.75%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

ADMA Biologics, Inc. is a specialty immune globulin company. It develops, manufactures and intends to market plasma-based biologics for the treatment and prevention of certain infectious diseases. The Company's target patient populations include immune-compromised individuals who suffer from an underlying...

See More

Key Turning Points

3rd Resistance Point 2.88
2nd Resistance Point 2.80
1st Resistance Point 2.75
Last Price 2.70
1st Support Level 2.63
2nd Support Level 2.55
3rd Support Level 2.50

See More

52-Week High 2.92
Last Price 2.70
Fibonacci 61.8% 2.19
Fibonacci 50% 1.97
Fibonacci 38.2% 1.74
52-Week Low 1.01

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar